SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
7.78
+0.22 (2.91%)
At close: May 22, 2026, 4:00 PM EDT
7.79
+0.01 (0.13%)
After-hours: May 22, 2026, 7:58 PM EDT
SLS Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SLS stock have an average target of 10, which predicts a 28.53% increase from the current stock price of 7.78.
Price Target: $10 (+28.53%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 12, 2026.
Analyst Ratings
The average analyst rating for SLS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +28.53% | Mar 12, 2026 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | -10.03% | Jul 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -61.44% | Nov 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -61.44% | Sep 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +2.83% | Nov 15, 2022 |
Financial Forecast
Revenue This Year
21.90M
Revenue Next Year
44.69M
from 21.90M
Increased by 104.08%
EPS This Year
-0.21
from -0.25
EPS Next Year
-0.15
from -0.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 22.8M | 46.5M | ||||
| Avg | 21.9M | 44.7M | ||||
| Low | 21.2M | 43.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | 112.2% | ||||
| Avg | - | 104.1% | ||||
| Low | - | 98.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.21 | -0.05 | ||||
| Avg | -0.21 | -0.15 | ||||
| Low | -0.22 | -0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.